Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.7%

98 terminated/withdrawn out of 1009 trials

Success Rate

84.4%

-2.1% vs industry average

Late-Stage Pipeline

7%

70 trials in Phase 3/4

Results Transparency

48%

255 of 532 completed trials have results

Key Signals

212 recruiting255 with results78 terminated20 withdrawn

Enrollment Performance

Analytics

N/A
408(48.6%)
Phase 2
187(22.3%)
Phase 1
156(18.6%)
Phase 3
38(4.5%)
Phase 4
32(3.8%)
Early Phase 1
19(2.3%)
840Total
N/A(408)
Phase 2(187)
Phase 1(156)
Phase 3(38)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1009)

Showing 20 of 1009 trials
NCT05933525Phase 2Completed

Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model.

Role: collaborator

NCT05933681Not ApplicableActive Not Recruiting

Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation

Role: collaborator

NCT07643974Early Phase 1Not Yet Recruiting

Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD

Role: collaborator

NCT07220681Not ApplicableRecruiting

Integrated Health Care for PTSD

Role: collaborator

NCT07436754Not ApplicableRecruiting

Clinical Trial Comparing the Efficacy of Two Teletherapy Programs at Improving Psychological Health in People With Brain Injury

Role: collaborator

NCT05699174Phase 3Recruiting

PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

Role: collaborator

NCT07621094Not ApplicableNot Yet Recruiting

Intraosseous Antibiotics for Osseointegration

Role: collaborator

NCT03873610Not ApplicableCompleted

Resiliency Training in Adolescents With NF1 and NF2

Role: collaborator

NCT02194582Active Not Recruiting

Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure

Role: collaborator

NCT06871410Phase 1Recruiting

Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Role: collaborator

NCT03947450Phase 2Recruiting

Autologous Volar Fibroblast Injection Into the Stump Site of Amputees

Role: collaborator

NCT01964859Phase 2Recruiting

Feasibility Study for Fibroblast Autologous Skin Grafts

Role: collaborator

NCT07637240Not Yet Recruiting

CRUISE System in Flight

Role: collaborator

NCT07447063Phase 4Not Yet Recruiting

The Impact of Dietary Salt on the Severity of Eczema

Role: collaborator

NCT04586049Active Not Recruiting

Cardiovascular and Neurovascular Regulation in GWI

Role: collaborator

NCT07075042Not ApplicableRecruiting

Comparing the Attentional Demands and Functional Outcomes in People With Transradial Amputation

Role: collaborator

NCT05137743Not ApplicableCompleted

Pilot Test of Apnea and Insomnia Relief for Veterans With Gulf War Illness

Role: collaborator

NCT04481048Phase 2Completed

Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1

Role: collaborator

NCT01132937Completed

Evaluation, Pathogenesis, and Outcome of Subjects With or Suspected Traumatic Brain Injury

Role: collaborator

NCT04722835Recruiting

Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers

Role: collaborator